dacarbazine,pegfilgrastim,doxorubicin,nivolumab,brentuximab vedotin,vinblastine,filgrastim
amgen,bms,seagen
['kudos', 'nivo', 's1826', 'cml']
from #asco23 to #icml23, nivo-avd in s1826 making the plenary rounds as presented by alex herrera; better tolerated by ctcae criteria than bv-avd, improved pfs, and an impressively collaborative and representative study by , kudos to this group for such an important study! 
Heme/Onc fellow @UCCancerCenter interested in aggressive lymphoma, novel therapeutics, and cellular therapies #lymsm #TcellRx. Views are my own.